(877) 330-2919
Have multiple conditions? Click here
Select your condition
Tell us what's ailing you or use the guide to select multiple conditions
Choose your location
Enter your Zip Code into the guide or click on a state to find trials near you
Speak to an expert
The quickest way to get started! Get instantly connected to the right trial

Mercy Cancer Center at Mercy Medical Center - Des Moines | Des Moines, Iowa

Name:Mercy Cancer Center at Mercy Medical Center - Des Moines
Phone: Click to View Phone #


Location

Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines, Iowa 50314

Trials at this Location

NameCityStateZip
Acute Pain Caused by Paclitaxel in Patients With Cancer Des MoinesIA50314
AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Des MoinesIA50314
AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer Des MoinesIA50314
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Des MoinesIA50314
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Des MoinesIA50314
Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Des MoinesIA50314
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Des MoinesIA50314
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Des MoinesIA50314
Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct Des MoinesIA50314
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Des MoinesIA50314
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Des MoinesIA50314
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary Des MoinesIA50314
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer Des MoinesIA50314
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Des MoinesIA50314
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Des MoinesIA50314
Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Des MoinesIA50314
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Des MoinesIA50314
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer Des MoinesIA50314
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Des MoinesIA50314
Collecting Tumor Samples From Patients With Gynecological Tumors Des MoinesIA50314
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Des MoinesIA50314
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Des MoinesIA50314
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme Des MoinesIA50314
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Des MoinesIA50314
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer Des MoinesIA50314
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Des MoinesIA50314
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Des MoinesIA50314
Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Des MoinesIA50314
Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Des MoinesIA50314
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Des MoinesIA50314
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Des MoinesIA50314
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Des MoinesIA50314
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Des MoinesIA50314
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Des MoinesIA50314
Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer Des MoinesIA50314
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Des MoinesIA50314
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Des MoinesIA50314
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Des MoinesIA50314
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Des MoinesIA50314
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Des MoinesIA50314
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Des MoinesIA50314
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Des MoinesIA50314
Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery Des MoinesIA50314
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Des MoinesIA50314
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Des MoinesIA50314
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Des MoinesIA50314
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms Des MoinesIA50314
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer Des MoinesIA50314
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer Des MoinesIA50314
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Des MoinesIA50314
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Des MoinesIA50314
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Des MoinesIA50314
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Des MoinesIA50314
S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer Des MoinesIA50314
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Des MoinesIA50314
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma Des MoinesIA50314
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy Des MoinesIA50314
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Des MoinesIA50314
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Des MoinesIA50314
Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer Des MoinesIA50314
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Des MoinesIA50314
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Des MoinesIA50314
Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Des MoinesIA50314
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Des MoinesIA50314

advanced trial search
  • Condition:
  • Zip:
    Radius:

  • Age:
    to
    Phase:

  • Healthy volunteer:
    Yes No

helpful resources
browse trials by condition
share this page
BROWSE CLINICAL TRIALS BY STATE
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
Featured Locations: Anaheim - Atlanta - Birmingham - Cleveland - DeLand - Jacksonville - Miami - Oklahoma City
Copyright 2013 Clinical Trials GPS | All Rights Reserved
About Us | Contact Us | Privacy Policy | Terms of Service | Sitemap
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site
Get connected to the right trial. Mercy Cancer Center at Mercy Medical Center - Des Moines
Create your account

Tell Us About Yourself


Are you healthy?
Do You Smoke
Overnight stay?
Phase:
Find Trials for the Following Conditions (choose all that apply)
  • Cardiology / Vascular Diseases






  • Dental / Maxillofacial Surgery

  • Dermatology / Plastic Surgery






  • Endocrinology





  • Gastroenterology








  • Hematology




  • Immunology / Infectious Diseases








  • Musculoskeletal




  • Nephrology / Urology






  • Neurology





  • Oncology












  • Ophthalmology

  • Orthopedics / Podiatry



  • Other



  • Otolaryngology


  • Pharmacology / Toxicology


  • Psychiatry / Psychology






  • Pulmonary / Respiratory Diseases








  • Reproductive






  • Rheumatology











Thanks for submitting your information!
You will be contacted by one of our Clinical Trials Specialists to help guide you through the process of finding the right trial for you!
Based on your responses, we have a few additional questions (optional):
✖



Forgot Password?
✖

✖